Signaling Pathways and Epigenetic Regulations in the Control of RORγt Expression in T Helper 17 Cells

REFERENCES

• Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature immunology. 2005;6(11):1123–1132.
   PubMed Web of Science ®Google Scholar
• Falvo JV, Jasenosky LD, Kruidenier L, Goldfeld AE. Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation. Adv Immunol 2013;118:37–128.
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunol 2005;6(11):1133–1141.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008;28(4):454–467.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485–517.
   PubMed Web of Science ®Google Scholar
• Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203(10):2271–2279.
   PubMed Web of Science ®Google Scholar
• Qu N, Xu M, Mizoguchi I, et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol 2013;2013:968549.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007;448(7152):484–487.
   PubMed Web of Science ®Google Scholar
• El-Behi M, Ciric B, Dai H, et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat immunol 2011;12(6):568–575.
   PubMed Web of Science ®Google Scholar
• Codarri L, Gyulveszi G, Tosevski V, et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011;12(6):560–567.
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8(9):950–957.
   PubMed Web of Science ®Google Scholar
• Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180(11):7423–7430.
   PubMed Web of Science ®Google Scholar
• Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010;140(6):845–858.
   Google Scholar
• Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006;441(7090):231–234.
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24(2):179–189.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441(7090):235–238.
   PubMed Web of Science ®Google Scholar
• Zuniga LA, Jain R, Haines C, Cua DJ. Th17 cell development: from the cradle to the grave. Immunol Rev 2013;252(1):78–88.
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008;28(4):445–453.
   PubMed Web of Science ®Google Scholar
• Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007;448(7152):480–483.
   PubMed Web of Science ®Google Scholar
• Onoda T, Rahman M, Nara H, et al. Human CD4+ central and effector memory T cells produce IL-21: effect on cytokine-driven proliferation of CD4+ T cell subsets. Int Immunol 2007;19(10):1191–1199.
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov, II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8(9):967–974.
   PubMed Web of Science ®Google Scholar
• Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 2009;9(2):91–105.
   PubMed Web of Science ®Google Scholar
• He YW, Deftos ML, Ojala EW, Bevan MJ. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 1998;9(6):797–806.
   PubMed Web of Science ®Google Scholar
• Hirose T, Smith RJ, Jetten AM. ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun 1994;205(3):1976–1983.
   PubMed Web of Science ®Google Scholar
• Medvedev A, Yan ZH, Hirose T, et al. Cloning of a cDNA encoding the murine orphan receptor RZR/ROR gamma and characterization of its response element. Gene 1996;181(1–2):199–206.
   PubMed Web of Science ®Google Scholar
• Villey I, de Chasseval R, de Villartay JP. RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma / TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter. Eur J Immunol 1999;29(12):4072–4080.
   PubMed Web of Science ®Google Scholar
• Eberl G, Marmon S, Sunshine MJ, et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004;5(1):64–73.
   PubMed Web of Science ®Google Scholar
• Eberl G, Littman DR. The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol Rev 2003;195:81–90.
   PubMed Web of Science ®Google Scholar
• Eberl G, Littman DR. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 2004;305(5681):248–251.
   PubMed Web of Science ®Google Scholar
• Kang HS, Angers M, Beak JY, et al. Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics 2007;31(2):281–294.
   PubMed Web of Science ®Google Scholar
• Jetten AM, Joo JH. Retinoid-related Orphan receptors (RORs): roles in cellular differentiation and development. Adv Dev Biol 2006;16:313–355.
   PubMedGoogle Scholar
• Jetten AM. Retinoid-related Orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Receptor Signaling 2009;7:e003.
   PubMedGoogle Scholar
• Ivanov, II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007;19(6):409–417.
   PubMed Web of Science ®Google Scholar
• Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008;8(5):337–348.
   PubMed Web of Science ®Google Scholar
• Diveu C, McGeachy MJ, Boniface K, et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 2009;182(9):5748–5756.
   PubMed Web of Science ®Google Scholar
• Mukasa R, Balasubramani A, Lee YK, et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010;32(5):616–627.
   PubMed Web of Science ®Google Scholar
• Huber M, Brustle A, Reinhard K, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A. 2008;105(52):20846–20851.
   PubMed Web of Science ®Google Scholar
• Brustle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007;8(9):958–966.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Kameswaran V, Zhang Y, et al. The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis. J Exp Med 2011;208(11):2321–2333.
   PubMed Web of Science ®Google Scholar
• Chen G, Hardy K, Pagler E, et al. The NF-kappaB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis. J Immunol 2011;187(9):4483–4491.
   PubMed Web of Science ®Google Scholar
• Zhang F, Meng G, Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol 2008;9(11):1297–1306.
   PubMed Web of Science ®Google Scholar
• Ratajewski M, Walczak-Drzewiecka A, Salkowska A, Dastych J. Upstream stimulating factors regulate the expression of RORgammaT in human lymphocytes. J Immunol. 2012;189(6):3034–3042.
   PubMed Web of Science ®Google Scholar
• Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007;282(13):9358–9363.
   PubMed Web of Science ®Google Scholar
• Wong LY, Hatfield JK, Brown MA. Ikaros sets the potential for Th17-lineage gene expression through effects on chromatin state in early T cell development. J Biol Chem 2013;288(49):35170–35179.
   PubMed Web of Science ®Google Scholar
• Ichiyama K, Sekiya T, Inoue N, et al. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-beta is mediated by suppression of eomesodermin. Immunity. 2011;34(5):741–754.
   PubMed Web of Science ®Google Scholar
• Yu X, Rollins D, Ruhn KA, et al. TH17 cell differentiation is regulated by the circadian clock. Science 2013;342(6159):727–730.
   PubMed Web of Science ®Google Scholar
• Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008;452(7188):773–776.
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007;448(7157):1058–1062.
   PubMed Web of Science ®Google Scholar
• Durant L, Watford WT, Ramos HL, et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010;32(5):605–615.
   PubMed Web of Science ®Google Scholar
• Harris TJ, Grosso JF, Yen HR, et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007;179(7):4313–4317.
   PubMed Web of Science ®Google Scholar
• Mathur AN, Chang HC, Zisoulis DG, et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007;178(8):4901–4907.
   PubMed Web of Science ®Google Scholar
• Hu CM, Jang SY, Fanzo JC, Pernis AB. Modulation of T cell cytokine production by interferon regulatory factor-4. J Biol Chem 2002;277(51):49238–49246.
   PubMed Web of Science ®Google Scholar
• Lohoff M, Mittrucker HW, Prechtl S, et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci U S A 2002;99(18):11808–11812.
   PubMed Web of Science ®Google Scholar
• Rengarajan J, Mowen KA, McBride KD, et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 2002;195(8):1003–1012.
   PubMed Web of Science ®Google Scholar
• Biswas PS, Gupta S, Chang E, et al. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest 2010;120(9):3280–3295.
   PubMed Web of Science ®Google Scholar
• Yi CH, Terrett JA, Li QY, et al. Identification, mapping, and phylogenomic analysis of four new human members of the T-box gene family: EOMES, TBX6, TBX18, and TBX19. Genomics 1999;55(1):10–20.
   PubMed Web of Science ®Google Scholar
• Gerondakis S, Grumont R, Gugasyan R, et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006;25(51):6781–6799.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 2003;13(1):43–47.
   PubMed Web of Science ®Google Scholar
• Ono M, Yaguchi H, Ohkura N, et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007;446(7136):685–689.
   PubMed Web of Science ®Google Scholar
• Djuretic IM, Levanon D, Negreanu V, et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 2007;8(2):145–153.
   PubMed Web of Science ®Google Scholar
• Nichogiannopoulou A, Trevisan M, Friedrich C, Georgopoulos K. Ikaros in hemopoietic lineage determination and homeostasis. Semin Immunol 1998;10(2):119–125.
   PubMed Web of Science ®Google Scholar
• Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394(6696):897–901.
   PubMed Web of Science ®Google Scholar
• Yu Y, Liu Y, Shi FD, et al. Cutting edge: Leptin-induced RORgammat expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol 2013;190(7):3054–3058.
   PubMed Web of Science ®Google Scholar
• Lee YK, Turner H, Maynard CL, et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009;30(1):92–107.
   PubMed Web of Science ®Google Scholar
• Lexberg MH, Taubner A, Forster A, et al. Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 2008;38(10):2654–2664.
   PubMed Web of Science ®Google Scholar
• Batten M, Li J, Yi S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006;7(9):929–936.
   PubMed Web of Science ®Google Scholar
• Stumhofer JS, Laurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006;7(9):937–945.
   PubMed Web of Science ®Google Scholar
• El-behi M, Ciric B, Yu S, et al. Differential effect of IL-27 on developing versus committed Th17 cells. J Immunol 2009;183(8):4957–4967.
   PubMed Web of Science ®Google Scholar
• Male V, Nisoli I, Gascoyne DM, Brady HJ. E4BP4: an unexpected player in the immune response. Trends Immunol 2012;33(2):98–102.
   PubMed Web of Science ®Google Scholar
• Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317(5835):256–260.
   PubMed Web of Science ®Google Scholar
• Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007;37(9):2396–2399.
   PubMed Web of Science ®Google Scholar
• Elias KM, Laurence A, Davidson TS, et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 2008;111(3):1013–1020.
   PubMed Web of Science ®Google Scholar
• Pino-Lagos K, Benson MJ, Noelle RJ. Retinoic acid in the immune system. Ann NY Acad Sci 2008;1143:170–187.
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99(10):3838–3843.
   PubMed Web of Science ®Google Scholar
• Spaggiari GM, Capobianco A, Becchetti S, et al. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107(4):1484–1490.
   PubMed Web of Science ®Google Scholar
• Ghannam S, Pene J, Torcy-Moquet G, et al. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 2010;185(1):302–312.
   PubMed Web of Science ®Google Scholar
• Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mut Res 2011;727(3):55–61.
   PubMed Web of Science ®Google Scholar
• Tian Y, Yang W, Song J, et al. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol 2013;33(15): 2810–2816.
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Chromatin modifications and their function. Cell 2007;128(4):693–705.
   PubMed Web of Science ®Google Scholar
• Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005;(2 Suppl 1):S4–S11.
   Google Scholar
• Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349(21):2042–2054.
   PubMed Web of Science ®Google Scholar
• Chen T, Li E. Structure and function of eukaryotic DNA methyltransferases. Curr Top Dev Biol 2004;60:55–89.
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128(4):683–692.
   PubMed Web of Science ®Google Scholar
• Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129(4):823–837.
   PubMed Web of Science ®Google Scholar
• Roh TY, Cuddapah S, Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 2005;19(5):542–552.
   PubMed Web of Science ®Google Scholar
• Schones DE, Cui K, Cuddapah S, et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008;132(5):887–898.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zang C, Rosenfeld JA, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008;40(7):897–903.
   PubMed Web of Science ®Google Scholar
• Wei G, Wei L, Zhu J, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009;30(1):155–167.
   PubMed Web of Science ®Google Scholar
• Tian Y, Jia Z, Wang J, et al. Global mapping of H3K4me1 and H3K4me3 reveals the chromatin state-based cell type-specific gene regulation in human Treg cells. PLoS One 2011;6(11):e27770.
   PubMed Web of Science ®Google Scholar
• Tian Y, Ni D, Yang W, et al. Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B. Carcinogenesis 2013;35(1):53–61.
   PubMed Web of Science ®Google Scholar
• Bending D, Newland S, Krejci A, et al. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol 2011;186(6):3373–3382.
   PubMed Web of Science ®Google Scholar
• Cohen CJ, Crome SQ, MacDonald KG, et al. Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J Immunol 2011;187(11):5615–5626.
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, Yang XP, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010;467(7318):967–971.
   PubMed Web of Science ®Google Scholar
• Schmidl C, Hansmann L, Andreesen R, et al. Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naive Treg. Eur J Immunol 2011;41(5):1491–1498.
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007;8(6):639–646.
   PubMed Web of Science ®Google Scholar
• Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204(8):1849–1861.
   PubMed Web of Science ®Google Scholar
• Nistala K, Adams S, Cambrook H, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010;107(33):14751–14756.
   PubMed Web of Science ®Google Scholar
• Boniface K, Blumenschein WM, Brovont-Porth K, et al. Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage. J Immunol 2010;185(1):679–687.
   PubMed Web of Science ®Google Scholar
• Kleinschek MA, Boniface K, Sadekova S, et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009;206(3):525–534.
   PubMed Web of Science ®Google Scholar
• Klug M, Rehli M. Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 2006;1(3):127–130.
   PubMed Web of Science ®Google Scholar
• Liu YL, Wu W, Xue Y, et al. MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation. Arch Virol 2013;158(9):1953–1963.
   PubMed Web of Science ®Google Scholar
• Donate PB, Fornari TA, Macedo C, et al. T cell post-transcriptional miRNA-mRNA interaction networks identify targets associated with susceptibility/resistance to collagen-induced arthritis. PLoS One 2013;8(1):e54803.
   PubMed Web of Science ®Google Scholar
• Huh JR, Littman DR. Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications. Eur J Immunol 2012;42(9):2232–2237.
   PubMed Web of Science ®Google Scholar